/

Cancer Research

/

TMEM200A: A Novel Oncogene Regulating EMT and PI3K/AKT in Gastric Cancer

/

Determining the Cell Viability of TMEM200A siRNA Transfected HGC-27 Cell Lines Using CCK-8 Assays (Video) | JoVE

JoVE Journal
Cancer Research

A subscription to JoVE is required to view this content. Sign in or start your free trial.

JoVE Journal Cancer Research

Determining the Cell Viability of TMEM200A siRNA Transfected HGC-27 Cell Lines Using CCK-8 Assays

Determining the Cell Viability of TMEM200A siRNA Transfected HGC-27 Cell Lines Using CCK-8 Assays (Video) | JoVE

TMEM200A: A Novel Oncogene Regulating EMT and PI3K/AKT in Gastric Cancer

DOI:

10.3791/200745-v

•

00:57 min

•

September 15, 2023

•

Yaowen Zhang, Shanshan Kuang, Hancheng Qin, Na Zhao, Yixin Yang, Jisheng Xie

¹Department of Histology and Embryology,Youjiang Medical University for Nationalities, ²Department of Pathophysiology,Youjiang Medical University for Nationalities

Tags

Keywords: Cell Viability TMEM200A SiRNA HGC-27 Cells CCK-8 Assays Cell Seeding Cell Incubation Absorbance Measurement Cell Knockdown Negative Control

Embed

ADD TO PLAYLIST

Usage Statistics

Related Videos

Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies (Video) | JoVE

Transfection of TMEM200A siRNA in Stomach Adenocarcinoma Cell Lines (Video) | JoVE

Quantification of mRNA in TMEM200A siRNA Transfected Stomach Adenocarcinoma Cells (Video) | JoVE

Protein Detection in TMEM200A siRNA Transfected Stomach Adenocarcinoma Cells Using Western Blotting (Video) | JoVE

Determining the Cell Viability of TMEM200A siRNA Transfected HGC-27 Cell Lines Using CCK-8 Assays (Video) | JoVE

Read Article